Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA Ophthalmology|February 8, 2024
Automated Machine Learning for Predicting Diabetic Retinopathy Progression From Ultra-Widefield Retinal ImagesPaolo S Silva, Dean Zhang, Cris Martin P Jacoba, et al.
Diabetes|February 12, 2025
Differential Effects of Retinol-Binding Protein 3 and Anti-VEGF Antibodies on Retinal Dysfunctions in Diabetic RetinopathyQin Li, Satoru Onizuka, Kyoungmin Park, et al.
IEEE Transactions on Medical Imaging|January 11, 2024
Geometric Correspondence-Based Multimodal Learning for Ophthalmic Image AnalysisYan Wang, Liangli Zhen, Tien-En Tan, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology. Retina|April 26, 2025
Detection of Center-Involved Diabetic Macular Edema with Visual Impairment using Multimodal Artificial Intelligence AlgorithmsTien-En Tan, Yi Pin Ng, Claire Calhoun, et al.
JAMA Ophthalmology|March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical TrialRaj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA|February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic RetinopathyRaj K Maturi, Adam R Glassman, Kristin Josic, et al.
Ophthalmology|April 30, 2010
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema, Michael J Elman, Lloyd Paul Aiello, et al.
Pageof 17